1. Home
  2. WPRT vs CUE Comparison

WPRT vs CUE Comparison

Compare WPRT & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WPRT
  • CUE
  • Stock Information
  • Founded
  • WPRT 1995
  • CUE 2014
  • Country
  • WPRT Canada
  • CUE United States
  • Employees
  • WPRT N/A
  • CUE N/A
  • Industry
  • WPRT Industrial Machinery/Components
  • CUE Biotechnology: Pharmaceutical Preparations
  • Sector
  • WPRT Industrials
  • CUE Health Care
  • Exchange
  • WPRT Nasdaq
  • CUE Nasdaq
  • Market Cap
  • WPRT 49.9M
  • CUE 48.0M
  • IPO Year
  • WPRT 1995
  • CUE 2018
  • Fundamental
  • Price
  • WPRT $3.06
  • CUE $0.78
  • Analyst Decision
  • WPRT Buy
  • CUE Strong Buy
  • Analyst Count
  • WPRT 3
  • CUE 3
  • Target Price
  • WPRT $6.33
  • CUE $3.00
  • AVG Volume (30 Days)
  • WPRT 15.2K
  • CUE 273.1K
  • Earning Date
  • WPRT 08-11-2025
  • CUE 08-13-2025
  • Dividend Yield
  • WPRT N/A
  • CUE N/A
  • EPS Growth
  • WPRT N/A
  • CUE N/A
  • EPS
  • WPRT N/A
  • CUE N/A
  • Revenue
  • WPRT $295,680,000.00
  • CUE $7,991,000.00
  • Revenue This Year
  • WPRT N/A
  • CUE N/A
  • Revenue Next Year
  • WPRT N/A
  • CUE $23.84
  • P/E Ratio
  • WPRT N/A
  • CUE N/A
  • Revenue Growth
  • WPRT N/A
  • CUE 13.83
  • 52 Week Low
  • WPRT $2.50
  • CUE $0.45
  • 52 Week High
  • WPRT $6.50
  • CUE $1.99
  • Technical
  • Relative Strength Index (RSI)
  • WPRT 53.05
  • CUE 58.42
  • Support Level
  • WPRT $2.96
  • CUE $0.65
  • Resistance Level
  • WPRT $3.15
  • CUE $0.88
  • Average True Range (ATR)
  • WPRT 0.12
  • CUE 0.07
  • MACD
  • WPRT 0.02
  • CUE 0.02
  • Stochastic Oscillator
  • WPRT 51.22
  • CUE 63.74

About WPRT Westport Fuel Systems Inc

Westport Fuel Systems Inc is an organization engaged in the engineering, manufacturing, and supply of alternative fuel systems and components for transportation applications. It has three operating segments; the Original Equipment Manufacturers segment-design, manufacture, and sell alternative fuel systems, components and electronics, and related engineering services, to OEMs that serve light-duty, medium-duty, and heavy-duty customers, the Independent Aftermarket segment includes IAM products, conversion kits, and components allow for the conversion of vehicles after being sold to the end-user through a network of dealers and installers, and Corporate includes public company activities, corporate oversight, financing and capital allocation.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: